S100-SPECT uncovers cellular and molecular events of pre-metastatic niche formation and following organ-specific cancer metastasis

Research output: Contribution to journalEditorialpeer-review

2 Citations (Scopus)

Abstract

Great progress has been made in in vivo imaging for cancer metastasis. Eisenblaetter et al. developed an innovative S100A8/A9-specific single photon emission computed tomography (SPECT) probe for imaging and succeeded in detecting the metastatic organ favored by the cancer before the cancer arrival. By utilizing this advanced method, researchers have also found that cancer-derived monocytes are the main source of the abundant production of S100A8/A9 in the pre-metastatic area. The CCL2-CCR2 axis is associated with S100A8/A9 production. Clinical establishment of this technique is expected to enable accurate prediction and monitoring of cancer metastasis during therapy.

Original languageEnglish
Pages (from-to)2649-2651
Number of pages3
JournalTheranostics
Volume7
Issue number10
DOIs
Publication statusPublished - 2017

Keywords

  • CCL2
  • CCR2
  • In vivo imaging
  • Inflammation
  • Monocytes
  • Organ-specific metastasis
  • Pre-metastatic niche
  • S100A8/A9

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Fingerprint Dive into the research topics of 'S100-SPECT uncovers cellular and molecular events of pre-metastatic niche formation and following organ-specific cancer metastasis'. Together they form a unique fingerprint.

Cite this